Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01612338 · ClinicalTrials.gov registry record · NA
Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives
A NA study of Breast Cancer and Breast Cancer in Young Women, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 1,290
- Enrollment target
- 2
- Study locations
NCT01612338 is a NA study of Breast Cancer and Breast Cancer in Young Women that has completed, run by University of Michigan. The registered enrollment target is 1,290 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01612338, a NA study of Breast Cancer and Breast Cancer in Young Women, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,290 participants
- Enrollment target
- 2
- Study locations
Study Summary
The University of Michigan (UM) Schools of Nursing, Public Health, and Medicine, the Michigan Department of Community Health (MDCH) and the Michigan Cancer Consortium (MCC) are conducting a multidisciplinary academic/practice three-year project to increase appropriate breast cancer screening for young breast cancer survivors and their cancer-free, female relatives at greatest risk for breast cancer. The aims of this project are to: 1) identify and survey 3000 breast cancer survivors reported to the Michigan Cancer Surveillance Program who were diagnosed between the ages of 20-45 years regarding their breast cancer screening utilization; 2) identify and survey the survivors' female relatives regarding their breast cancer screening utilization; and 3) implement two versions (targeted vs. enhanced tailored) of an evidence-based intervention recommended by the Guide to Community Preventive Services to increase breast cancer screening. A follow-up survey will assess the effectiveness of each intervention on a) breast cancer screening utilization; b) perceived barriers and facilitators to screening; c) self-efficacy in utilizing screening services; d) family support related to screening; e) knowledge of the genetics of breast cancer and personal risk factors; and f) satisfaction with the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Targeted
- BEHAVIORAL Enhanced Tailored
Study Locations (2)
Michigan
- University of Michigan School of Nursing - Ann Arbor
- Michigan Department of Community Health - Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,290 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01612338
The ClinicalTrials.gov registry entry for NCT01612338 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,290 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (54% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Targeted is the first listed.
NCT01612338 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01612338 about?
NCT01612338 is a clinical study titled "Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives". The University of Michigan (UM) Schools of Nursing, Public Health, and Medicine, the Michigan Department of Community Health (MDCH) and the Michigan Cancer Consortium (MCC) are conducting a multidisciplinary academic/practice three-year project to increase appropriate breast cancer screening for you...
What is the current status of trial NCT01612338?
This trial is currently completed. It is a NA study. The enrollment target is 1,290 participants. The study started on 2012-07. Estimated completion is 2014-09.
What conditions does trial NCT01612338 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer in Young Women, Breast Cancer in Women With a Strong Family History.
What interventions are being tested in trial NCT01612338?
The interventions under investigation include: Targeted (BEHAVIORAL), Enhanced Tailored (BEHAVIORAL).
Who is sponsoring clinical trial NCT01612338?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01612338 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.